The effect of orlistat on weight reduction in obese and overweight Korean patients
The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
Obesity is a chronic metabolic disease that affects an increasing number of people around the world. There have been limited studies evaluating the weight loss effects of orlistat in the Korean population, whose diet is different from that of the Caucasian population. The primary objective of this study was to evaluate the effect of orlistat on the weight and body mass index of obese and overweight Korean patients. The secondary objective was to evaluate the effects of orlistat on risk factors for obesity and metabolic disorders. Obese adult patients with a body mass index greater than 25 kg/m(2) who received 120 mg of orlistat three times daily for 24 weeks were included in this study. Patients were retrospectively evaluated for changes in body weight and body mass index, as well as waist and hip circumference, body fat levels, serum lipid levels, fasting glucose levels, and blood pressure. The evaluation included 63 patients. Treatment with orlistat for 4, 12, or 24 weeks significantly decreased the weight, body mass index, waist circumference, and hip circumference compared to that at the baseline. The average weight loss was 3.0 kg at 12 weeks and 3.6 kg at 24 weeks, which indicated a 3.8 and 4.6 % decrease from initial weight, respectively. The number of patients who lost more than 10 % of their initial body weight was 3 (4.8 %) at 12 weeks and 27 (7.9 %) at 24 weeks. About 27 % of patients reported gastrointestinal-related adverse effects with orlistat, but no serious a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Pi-Sunyer, F. X. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00006 · Cited by 1,371
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11509-4 · Cited by 1,237
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947
Body Mass Index and Mortality in a Prospective Cohort of US Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (2000) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200003000-00010 · Cited by 918
American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease
Eckel, R. H., & Krauss, R. M. (1998) · Circulation · doi:10.1161/01.cir.97.21.2099 · Cited by 805
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Rosenbaum, M., Leibel, R. L., & Hirsch, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370606 · Cited by 584
Research works printed but not linked: 1
- Chon, S., C. Park, G. Koh, S. Oh, J.T. Woo, S.W. Kim, J.W. Kim, Y.S. Kim, H.Y. Son, B.Y. Cha, K.H. Yoon, H.S. Kwon, B.S. Cha, and H.C. Lee. 2004. The effect of orlistat in obese patients with type 2 diabetes: Benefit on abdominal obesity and glycemic control. Journal of Korean Society for the Study of Obesity 13: 281–292.
Cited by
The superoxide free radical: its biochemistry and pathophysiology.
McCord, J. M. (1983) · PubMed · Cited by 187
Gorgojo‐Martínez, J. J., Basagoiti‐Carreño, B., Sanz‐Velasco, A., Serrano‐Moreno, C., & Almodóvar‐Ruiz, F. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13399 · Cited by 82
Ahmad, N. N., Robinson, S., Kennedy‐Martin, T., Poon, J. L., & Kan, H. (2021) · Obesity Reviews · doi:10.1111/obr.13326 · Cited by 69
“Another TABLE 5 Cardiometabolic risk factors affected by AOM therapy in real-world practice Study Study population Study duration, months SBP DBP HR TG TC LDLC HDLC FBG HbA1c ORLISTAT Ahn et al.(23) General obesity 6 #* #* # #* # $ #* Gorgojo-Martínez et al.”
BackgroundEffectiveness and safety of drugs for obesity
Henderson Lewis, K., Sloan, C. E., Bessesen, D. H., & Arterburn, D. (2024) · BMJ · doi:10.1136/bmj-2022-072686 · Cited by 66
Chinese Herbal Medicine for Obesity: A Randomized, Double-Blinded, Multicenter, Prospective Trial
Zhou, Q., Chang, B., Chen, X., Zhou, S., Zhong, Z., Zhang, L., Sun, X., Zhou, Y., Xie, W., Liu, H., et al. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500840 · Cited by 42
Metadata
- Authors
- Ahn, S. M., Kim, H., Ji, E., Han, N., & Oh, J. M.
- Affiliations
- Sookmyung Women's University (KR)
- Gachon University (KR)
- Seoul National University (KR)
- Corresponding author
- Oh, Jung Mi
- Venue
- Archives of Pharmacal Research
- Published
- 2013-07-10
- Volume
- 37
- Issue
- 4
- Pages
- 512-519
- ISSN
- 0253-6269 (ISSN-L)
- 1976-3786
- OpenAlex
- W1995475244
- Semantic Scholar
- 05fbe40d69b5ea9049f0951782a9f3ffc231b782
- Cited by
- 14
- References
- 28
- Citations by year
- 2024: 7 · 2023: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2015: 1 · 2014: 1
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Pharmacal Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- orlistat, weight loss, obesity, overweight, Korean patients, body mass index, waist circumference, serum lipids, fasting blood glucose, blood pressure, gastrointestinal adverse effects, anti-obesity drugs
- MeSH terms
- Orlistat, Adipose Tissue, Blood Glucose, Blood Pressure, Fasting, Female, Humans, Lactones, Lipids, Male, Middle Aged, Obesity, Risk Factors, Weight Loss, Body Mass Index, Asian People, Waist-Hip Ratio, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of orlistat on weight reduction in obese and overweight Korean patients. https://app.cochat.ai/papers/10.1007/s12272-013-0201-8
- The paper
- Ahn, S. M., Kim, H., Ji, E., Han, N., & Oh, J. M. (2014). The effect of orlistat on weight reduction in obese and overweight Korean patients. Archives of Pharmacal Research. https://doi.org/10.1007/s12272-013-0201-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.